SIRT1 in Secretory Organ Cancer
Mammalian silent information regulator 1 (SIRT1) is reported to play a role in cancers of the secretory organs, including thyroid, pancreatic endocrine, and ovarian tumors [1, 2, 3, 4]. A recent meta-analysis conducted on 37 selected studies of human cancers analyzed the correlations of overall surv...
Main Author: | Raffaele Frazzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00569/full |
Similar Items
-
Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity
by: John R. P. Knight, et al.
Published: (2013-01-01) -
Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer
by: Khaldoun Rifaï, et al.
Published: (2018-10-01) -
Zyxin inhibits the epithelial–mesenchymal transition process in gastric cancer by upregulating SIRT1
by: Jing Lou, et al.
Published: (2023-10-01) -
The Two-Faced Role of SIRT6 in Cancer
by: Francesco Fiorentino, et al.
Published: (2021-03-01) -
Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection
by: Emanuele Fabbrizi, et al.
Published: (2023-03-01)